{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:52:23Z","timestamp":1776415943317,"version":"3.51.2"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bpa.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:14:39Z","timestamp":1589361279000},"page":"713-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is there a place for genetics in the management of PONV?"],"prefix":"10.1016","volume":"34","author":[{"given":"Keith","family":"Candiotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrama","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-3620","authenticated-orcid":false,"given":"Mariana Rubini","family":"Silva Ceschim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2020.05.002_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bja.2017.08.003","article-title":"Simplified algorithm for the prevention of postoperative nausea and vomiting: a before-and-after study","volume":"120","author":"Dewinter","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.05.002_bib2","first-page":"617","article-title":"An update on the management of postoperative nausea and vomiting","volume":"31","author":"Cao","year":"2017","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.bpa.2020.05.002_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1213\/ANE.0000000000000002","article-title":"Consensus guidelines for the management of postoperative nausea and vomiting","volume":"118","author":"Gan","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/ALN.0000000000002133","article-title":"Amisulpride prevents postoperative nausea and vomiting in patients at high RiskA randomized, double-blind, placebo-controlled trial","volume":"128","author":"Kranke","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.05.002_bib5","first-page":"137","article-title":"What is new in the battle against postoperative nausea and vomiting?","volume":"32","author":"Tateosian","year":"2018","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/0259-1162.179310","article-title":"Postoperative nausea and vomiting: a simple yet complex problem","volume":"10","author":"Shaikh","year":"2016","journal-title":"Anesth Essays Res"},{"key":"10.1016\/j.bpa.2020.05.002_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00000542-199909000-00022","article-title":"A\u00a0simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers","volume":"91","author":"Apfel","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.05.002_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bja.2018.02.025","article-title":"CHRM3 rs2165870 polymorphism is independently associated with postoperative nausea and vomiting, but combined prophylaxis is effective","volume":"121","author":"Klenke","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.05.002_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/ALN.0b013e31821810c7","article-title":"Genome-wide Association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting","volume":"115","author":"Janicki","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.05.002_bib10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/anae.13082","article-title":"TACR1 gene polymorphism and sex differences in postoperative nausea and vomiting","volume":"70","author":"Hayase","year":"2015","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bpa.2020.05.002_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2013.10.037","article-title":"Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting","volume":"722","author":"Horn","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpa.2020.05.002_bib12","author":"National Human Genome Research Institute"},{"key":"10.1016\/j.bpa.2020.05.002_bib13","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1200\/JCO.2002.09.064","article-title":"Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes","volume":"20","author":"Kaiser","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpa.2020.05.002_bib14","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1200\/JCO.2003.05.164","article-title":"Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients","volume":"21","author":"Tremblay","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpa.2020.05.002_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00008571-200405000-00001","article-title":"Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists","volume":"14","author":"Kaiser","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bpa.2020.05.002_bib16","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1213\/ane.0b013e3181b2359b","article-title":"Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting?","volume":"109","author":"Rueffert","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s11605-018-3788-8","article-title":"Genetic factors associated with postoperative nausea and vomiting: a systematic review","volume":"22","author":"L\u00f3pez-Morales","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpa.2020.05.002_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/EJA.0000000000001014","article-title":"A\u00a0serotonin transporter polymorphism is associated with postoperative nausea and vomiting: an observational study in two different patient cohorts","volume":"36","author":"Stamer","year":"2019","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/EJA.0000000000000320","article-title":"The role of the dopamine D2 receptor TaqIA polymorphism","volume":"33","author":"Frey","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.autneu.2016.09.017","article-title":"Exploring the multifactorial nature of postoperative nausea and vomiting in women following surgery for breast cancer","volume":"202","author":"Wesmiller","year":"2017","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.bpa.2020.05.002_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/ija.IJA_724_18","article-title":"Comparing the efficacy of aprepitant and ondansetron for the prevention of postoperative nausea and vomiting (PONV): a double blinded, randomised control trial in patients undergoing breast and thyroid surgeries","volume":"63","author":"Jeyabalan","year":"2019","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.bpa.2020.05.002_bib22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jopan.2014.11.013","article-title":"Aprepitant: a new modality for the prevention of postoperative nausea and vomiting: an evidence-based review","volume":"30","author":"Milnes","year":"2015","journal-title":"J\u00a0Perianesth Nurs"},{"key":"10.1016\/j.bpa.2020.05.002_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11695-017-2797-0","article-title":"The role of aprepitant in prevention of postoperative nausea and vomiting after bariatric surgery","volume":"28","author":"Therneau","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.bpa.2020.05.002_bib24","first-page":"45","article-title":"Genetic contribution to PONV risk","volume":"39","author":"Klenke","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.bpa.2020.05.002_bib25","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"New Eng J Med"},{"key":"10.1016\/j.bpa.2020.05.002_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00008571-199808000-00001","article-title":"Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research","volume":"8","author":"Kalow","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bpa.2020.05.002_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2217\/fmb.15.37","article-title":"Genetic variation in pattern recognition receptors: functional consequences and susceptibility to infectious disease","volume":"10","author":"Jaeger","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib28","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1213\/01.ANE.0000219597.16143.4D","article-title":"Risk factors for postoperative nausea and vomiting","volume":"102","author":"Gan","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000542-200503000-00011","article-title":"The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?","volume":"102","author":"Candiotti","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.05.002_bib30","first-page":"RA322","article-title":"Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting","volume":"11","author":"Janicki","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.bpa.2020.05.002_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3565(25)20152-5","article-title":"Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles","volume":"278","author":"Aklillu","year":"1996","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.bpa.2020.05.002_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-199706000-00003","article-title":"Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians","volume":"7","author":"McLellan","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bpa.2020.05.002_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2004.01.004","article-title":"Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population","volume":"50","author":"Scordo","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bpa.2020.05.002_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0009-9236(95)90151-5","article-title":"Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population","volume":"57","author":"Agundez","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bpa.2020.05.002_bib35","first-page":"284","article-title":"Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bpa.2020.05.002_bib36","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/clinchem\/48.9.1412","article-title":"Rapid and reliable method for cytochrome P450 2D6 genotyping","volume":"48","author":"Stamer","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpa.2020.05.002_bib37","first-page":"119","article-title":"The effect of ethnicity on the incidence of postoperative nausea and vomiting in moderate to high risk patients undergoing general anesthesia in South Africa: a controlled observational study","volume":"24","author":"Alli","year":"2017","journal-title":"Middle East J Anaesthesiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib38","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1213\/ANE.0b013e3181da9005","article-title":"Reduced incidence of postoperative nausea and vomiting in black South Africans and its utility for a modified risk scoring system","volume":"110","author":"Rodseth","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib39","article-title":"Singapore general hospital experience on ethnicity and the incidence of postoperative nausea and vomiting after elective orthopedic surgeries","author":"Leong","year":"2015","journal-title":"J\u00a0Anesthesiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00228-010-0866-6","article-title":"Adverse drug reactions in internal medicine units and associated risk factors","volume":"66","author":"S\u00e1nchez Mu\u00f1oz-Torrero","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.05.002_bib41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pharmthera.2009.10.011","article-title":"Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in\u00a0vivo information","volume":"125","author":"Hisaka","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bpa.2020.05.002_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bpa.2020.05.002_bib43","first-page":"1307","article-title":"Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles","volume":"10","author":"Ingelman-Sundberg","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpa.2020.05.002_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra020021","article-title":"Genomic medicine: inheritance and drug response","volume":"348","author":"Weinshilboum","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2020.05.002_bib45","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1073\/pnas.90.24.11825","article-title":"Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine","volume":"90","author":"Johansson","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpa.2020.05.002_bib46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/bja\/aen230","article-title":"Risk factors for severe postoperative nausea and vomiting in a randomized trial of nitrous oxide-based vs nitrous oxide-free anaesthesia","volume":"101","author":"Leslie","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.05.002_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1213\/00000539-199401000-00004","article-title":"The postoperative interview: assessing the risk factors for nausea and vomiting","volume":"78","author":"Cohen","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib48","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1213\/ane.0b013e318167cc3a","article-title":"The effects of oral ondansetron disintegrating tablets of at-home emesis in pediatric patients after ear-nose-throat surgery","volume":"106","author":"Davis","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1213\/01.ANE.0000155261.27335.29","article-title":"A\u00a0double-blind comparison of intravenous ondansetron and placebo for preventing post-operative emesis in 1- to 24-month-old pediatric patients after surgery under general anaesthesia","volume":"101","author":"Khalil","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib50","first-page":"30","article-title":"The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative vomiting following craniotomy: two studies in children and young adults","volume":"31","author":"Neufeld","year":"2009","journal-title":"Can J Neurosci Nurs"},{"key":"10.1016\/j.bpa.2020.05.002_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0090-9556(25)08368-0","article-title":"The polymorphic cytochrome p-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron","volume":"22","author":"Fischer","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpa.2020.05.002_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/pgs.14.168","article-title":"Pharmacogenetics of chemotherapy-induced nausea and vomiting","volume":"16","author":"Sugino","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bpa.2020.05.002_bib53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0090-9556(25)09187-1","article-title":"Characterization of the cytochrome p450 enzymes involved in the in\u00a0vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists","volume":"24","author":"Sanwald","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpa.2020.05.002_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2146\/ajhp150273","article-title":"Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing","volume":"73","author":"Hocum","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bpa.2020.05.002_bib55","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0090-9556(25)06820-5","article-title":"Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans","volume":"23","author":"Dixon","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bpa.2020.05.002_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2125.1994.tb04294.x","article-title":"The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolizers of debrisoquine","volume":"37","author":"Ashforth","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.05.002_bib57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1099800412449181","article-title":"The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients","volume":"15","author":"Wesmiller","year":"2013","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.bpa.2020.05.002_bib58","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00228-015-1857-4","article-title":"Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients","volume":"71","author":"Dong","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.05.002_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cpt.598","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron","volume":"102","author":"Bell","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bpa.2020.05.002_bib60","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.17219\/acem\/69451","article-title":"CYPD26 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting","volume":"27","author":"Niewi\u0144ski","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.bpa.2020.05.002_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1006304","article-title":"The path to personalized medicine","volume":"363","author":"Hamburg","year":"2010","journal-title":"New Eng J Med"},{"key":"10.1016\/j.bpa.2020.05.002_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/69.supplement_1.33S","article-title":"Postoperative nausea and vomiting in day-case surgery","volume":"69","author":"Wetchler","year":"1992","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.05.002_bib63","first-page":"1085","article-title":"Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists","volume":"88","author":"Macario","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2253-6-6","article-title":"Anesthesiologists' practice patterns for treatment of postoperative nausea and vomiting in the ambulatory Post Anesthesia Care Unit","volume":"6","author":"Macario","year":"2006","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bpa.2020.05.002_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1213\/ANE.0b013e318254285e","article-title":"Post-operative nausea and vomiting: then & now","volume":"115","author":"Habib","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.05.002_bib66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/aas.12651","article-title":"Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anesthesia practice","volume":"60","author":"Feldheiser","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bpa.2020.05.002_bib67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrd2825","article-title":"The microeconomics of personalized medicine: today's challenge and tomorrow's promise","volume":"8","author":"Davis","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bpa.2020.05.002_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1470-2045(10)70097-8","article-title":"Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism","volume":"11","author":"Relling","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpa.2020.05.002_bib69","first-page":"467","article-title":"Pharmacogenomics and individualized medicine: translating science into practice","volume":"92","author":"Crews","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bpa.2020.05.002_bib70","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00221-014-3968-z","article-title":"Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy induced nausea and vomiting","volume":"232","author":"Janicki","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bpa.2020.05.002_bib71","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1124\/pr.58.3.6","article-title":"Pharmacogenetics, drug-metabolizing enzymes, and clinical practice","volume":"58","author":"Gardiner","year":"2006","journal-title":"Pharmacol Rev"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:50:10Z","timestamp":1776412210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689620300355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1521689620300355"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.05.002","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a place for genetics in the management of PONV?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}